As of 2026-05-16, the Intrinsic Value of Solid Biosciences Inc (SLDB) is -8.86 USD. This SLDB valuation is based on the model Peter Lynch Fair Value. With the current market price of 6.92 USD, the upside of Solid Biosciences Inc is -228.02%.
Based on its market price of 6.92 USD and our intrinsic valuation, Solid Biosciences Inc (SLDB) is overvalued by 228.02%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -8.86 - -8.86 | -8.86 | -228.02% |
| P/E | (30.83) - (34.83) | (33.84) | -589.0% |
| DDM - Stable | (9.66) - (23.41) | (16.54) | -339.0% |
| DDM - Multi | (0.47) - (0.90) | (0.62) | -108.9% |
| Market Cap (mil) | 680.86 |
| Beta | 0.86 |
| Outstanding shares (mil) | 98.39 |
| Enterprise Value (mil) | 620.96 |
| Market risk premium | 4.60% |
| Cost of Equity | 13.82% |
| Cost of Debt | 5.00% |
| WACC | 8.75% |